Attacking lymphoma at the source

(Ecole Polytechnique F é d é rale de Lausanne) The efficacy of target specific therapies in lymphoma is limited to subgroups of patients. EPFL scientists have identified a mechanism that confers resistance against a common therapy for lymphoma. They propose an alternative treatment that targets lymphoma signaling at its root, and show that it can be effective in a broader group of patients. The study is published in the journal Blood.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news